Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy

Abstract Background The objective of this study was to evaluate if mammography screening attendance is associated with a reduction in late-stage breast cancer incidence. Methods The cohort included over 400,000 Italian women who were first invited to participate in regional screening programmes duri...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 75; pp. 109 - 116
Main Authors: Puliti, Donella, Bucchi, Lauro, Mancini, Silvia, Paci, Eugenio, Baracco, Susanna, Campari, Cinzia, Canuti, Debora, Cirilli, Claudia, Collina, Natalina, Conti, Giovanni Maria, Di Felice, Enza, Falcini, Fabio, Michiara, Maria, Negri, Rossella, Ravaioli, Alessandra, Sassoli de' Bianchi, Priscilla, Serafini, Monica, Zorzi, Manuel, Caldarella, Adele, Cataliotti, Luigi, Zappa, Marco
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-04-2017
Elsevier Science Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background The objective of this study was to evaluate if mammography screening attendance is associated with a reduction in late-stage breast cancer incidence. Methods The cohort included over 400,000 Italian women who were first invited to participate in regional screening programmes during the 1990s and were followed for breast cancer incidence for 13 years. We obtained individual data on their exposure to screening and correlated this with total and stage-specific breast cancer incidence. Socio-economic status and pre-screening incidence data were used to assess the presence of self-selection bias. Results Overall, screening attendance was associated with a 10% excess risk of in situ and invasive breast cancer (IRR = 1.10; 95% confidence interval (CI): 1.06–1.14), which dropped to 5% for invasive cancers only (IRR = 1.05; 95% CI: 1.01–1.09). There were significant reductions among attenders for specific cancer stages; we observed a 39% reduction for T2 or larger (IRR = 0.61; 95% CI: 0.57–0.66), 19% for node positives (IRR = 0.81; 95% CI: 0.76–0.86) and 28% for stage II and higher (IRR = 0.72; 95% CI: 0.68–0.76). Our data suggest that the presence of self-selection bias is limited and, overall, invited women experienced a 17% reduction of advanced cancers compared with pre-screening rates. Conclusions Comparing attenders' and non-attenders' stage-specific breast cancer incidence, we have estimated that screening attendance is associated with a reduction of nearly 30% for stages II+.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2016.12.030